Oncology Clinical Trials Market Expected to Reach US ~$16.63 billion and CAGR 5.6% by 2028 – Polaris Market Research
The global Oncology Clinical Trials Market size is expected to reach USD 16.63 billion by 2028 according to a new study by Polaris Market Research.
Pancreatic cancer has a poor prognosis of just 1 to 3 years of survival. In a day, about 16 people were suffering from intestinal stromal tumors and around 60,000 new cases of renal carcinoma were observed in the U.S alone. The factors listed above reflect a growing incidence of cancer and an increasing need for successful care for different forms of cancer. Study on cancer care is going ahead at a rapid rate.
Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/oncology-clinical-trials-market/request-for-sample
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
A change from chemotherapy protocols to molecularly targeted immunotherapy agents has been observed. Cancer continues to present new problems and opportunities for pharmacological action. As a result, the pharmaceutical industry continues to produce oncology drugs at an unprecedented pace.
In the Asia Pacific, the market demand for oncology clinical trials is expected to witness the fastest growth over the forecast period, due to the growing availability of a wide patient pool to promote the recruitment of candidates. According to Asia Pacific’s largest expert biotech company CRO. The area has become the chosen destination for clinical studies due to the low density of the trial and a large number of active investigators.
Many biotechnological companies pursuing CRO oncology services are increasingly turning to this field. For example, the EMA issued guidelines for accelerating the evaluation of qualifying medicines in 2015. In 2016, the Priority Medicines (PRIME) scheme was introduced to identify certain drugs at an early stage of production that has the potential to meet unmet medical needs.
Buy a Premium Report – https://www.polarismarketresearch.com/checkouts/8621
Market participants operating in the oncology clinical trials industry include PAREXEL International Corporation, PRA Health Sciences, Syneos Health, Medpace, Novotech, Pivotal, ICON Plc, Wuxi AppTec, Eli Lilly and Company, Novo Nordisk A/S, Pfizer, and Clinipace.
Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/oncology-clinical-trials-market/inquire-before-buying
(You may enquire about a reported quote OR available discount offers to our sales team before purchase.)
Polaris Market Research has segmented the oncology clinical trials market report on the basis of phase, study design, cancer type, and region:
Oncology Clinical Trials, Phase Outlook (Revenue – USD Million, 2016 – 2028)
- Phase I
- Phase II
- Phase III
- Phase IV
Oncology Clinical Trials, Study Design Outlook (Revenue – USD Million, 2016 – 2028)
- Expanded Access
Oncology Clinical Trials, Cancer Type Outlook (Revenue – USD Million, 2016 – 2028)
- Lung cancer
- Breast cancer
- Thyroid cancer
- Liver cancer
- Skin cancer
- Pancreatic cancer
- Prostate cancer
- Colon & rectal cancer
- Urinary system cancer
- Other cancer
Browse detailed report with in-depth TOC – Oncology Clinical Trials Market
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.
Polaris Market Research